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This paper presents a 2-year series of 26 consecutive pancreatectomies for periampullary cancer where the
pancreatic tail was closed with a stapler in order to avoid complications related to a pancreatico-digestive
anastomosis. The follow-up period was 14 months or more. Seven patients developed operative complica-
tions. Pancreatic fistulas developed in 3 patients. The fistulas closed spontaneously in 2 of the patients after
2-4 months, lntraabdominal abscesses developed in 4 patients and required surgical drainage. In of these
patients, the abscess eroded a large vessel with a fatal outcome resulting in an operative mortality rate of
3.8%. A transient postoperative gastric stasis was observed in seven patients. Postoperative hospital median
stay was 27 days (range 10-83 days). Eighteeen patients have died after 4--30 months in recurrent disease and
seven patients are alive after a follow-up period of 15-29 months. Pancreatic endocrine function seemed well
preserved; diabetes mellitus has developed in only one patient. In conclusion, it appears that subtotal
pancreatectomy with closure of the pancreatic remnant with staples gives a low morbidity and mortality.
Although the conclusion should be tempered by the small number of patients, the results justify continued
evaluation of this technique with long-term follow-up.
Despite aggressive surgical attempts, the prognosis of pancreatic carcinoma has re-
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mained poor -. Already at the time ofdiag,nsis, most patients have distant metastases
or are otherwise not fit for major surgery J.,o. For those whose tumour is considered
resectable, the operative approach has been a matter of discussion, and both subtotal
and total pancreatectomy have been advocated 5,8-16.
Insufficiency ofa pancreato-digestive anastomosis is a common and frequently lethal
complication after pancreatic, surerY.6.;a7- 20because of leakage of pancreatic secretion with"abscess and/or fistula formation Therefore, attempts to improve the results of
partial pancreatectomy must be directed towards this weakness of the operative
procedure. Several technical solutions have been presented: mucosa to mucosa-anas-
tomosis; splints in the anastomosis; obstruction of the outflow of pancreatic juice by
means of ligation; stapling of the pancreatic remnant, instillation of trolamine (Ethi-21-26. ThisblocR) into the pancreatic duct; open drainage; or doublejejunal loop report
presents our preliminary experience ofan extended pancreatic resection combined with
stapling the pancreatic remnant without reestablishing pancreato- digestive continuity.
Correspondence to: Bo Ahr6n, Dr. Department of Surgery, Lund University S-221 85 LUND, Sweden.
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PATIENTS
During a 2 year period, July 1985-June 1987, a total of69 patients with newly diagnosed
carcinoma of the exocrine pancreatic head (n 56), the ampulla ofVater (n 8), or the
distal choledochal duct (n 5) were treated at the Department of Surgery in Lund. Of
these, 26 patients (38%) were considered to have a resectable tumour and underwent
subtotal pancreatectomy with duodenectomy. Seventeen patients had carcinoma ofthe
pancreatic head, 7 had cancer of the Vaterian papilla, and 2 had a choledochal
carcinoma. The men age of the resected patients was 6310 (SD) years (range 40-80
years). The operation was considered radical if as judged after the operation all
malignant tissue had been removed. Otherwise, the operation was considered to be
palliative.
OPERATIVE PROCEDURE
The operation starts with extensive dissection of the retroduodenal region, the inferior
vena cava from above the left renal vein and 10 cm downward, and ofthe hepatoduode-
nal and gastrohepatic ligaments. The gallbladder is excised. All tissue but the major
arteries, the portal vein and the bile ducts, are removed from the hilum ofthe liver down
to the origin of the coeliac artery. All identifiable lymph glands are sent for separate
histologic examination. The coeliac plexus is included in the resection. The pancreas is
divided with stapler above the portal vein. The pancreas to the right of the portal vein
is removed together with the duodenum, adjacent retroperitoneal tissue, two thirds of
the stomach, the proximaljejunum and the extrahepatic biliary tree approximately one
cm below the junction of the hepatic ducts. Care is taken to remove all tissue on the
posterior and right sides of the superior mesenteric and portal veins and the superior
mesenteric artery, from the hilum of the liver and the aorta, respectively, down to the
first jejunal branches. About half of the remaining pancreas (approximately the body)
is dissected from the splenic vessels before the pancreas is again stapled off, with a TA55
instrument (the first 14 patients in the series) or RL60 (the last 12 patients in the series),
6-7 cm from the end of the tail. In addition, the pancreatic duct is suture-ligated and,
in some cases, a running 2-0 Prolene suture is used to reinforce the closure ofthe severed
end ofthe pancreas. Hepatojejunostomy is fashioned with a 60 cmjejunal Roux-en-Y-
loop end to side and followed gastrojejunostomy to the posterior or anterior side ofthe
stomach; the end of the Roux loop is placed subcutaneously. A separate incision was
made for placement of a rubber drain down to the peripancreatic area.
FOLLOW UP
The patients have been regularly followed by the operating surgeon. The last patient
in this series has been followed now for 14 months. The regular follow-up has included
computed tomography of the upper abdomen every third month.
RESULTS
Fifteen of the 26 patients had an over-all uneventful postoperative course. Median
postoperative hospital stay was 27 days (range 10-83 days; Table 1). In three patients,
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the drainage from the incision used for the abdominal drain continued more than l0
days without the existence of any abscess; these patients were defined as having
developed pancreatocutaneous fistulas. This complication did not, however, cause
significant morbidity. The fistulas closed spontaneously after 2-4 months. Secretion
from the fistulas was collected in a colostomy bag and did not cause irritation of the
skin or other discomfort. Frequent postoperative estimations did not disclose elevation
of serum amylase levels. Four patients developed intraabdominal abscesses which
required surgical drainage. These abscesses were located peripancreatically and were
found to contain infected material. In one of these patients, the abscess eroded a large
vessel which resulted in a profound hemorrhage with a fatal outcome. This was the only
mortality in this series of patients, yielding a mortality rate of 3.8%.
Most patients showed some signs ofdelayed gastric and/or intestinal emptying which
was the main reason behind the relatively long hospital stay. In seven of them, gastric
or jejunal dysfunction required treatment with nasogastric tube and intravenous
infusion more than 10 days because of inability to ingest more than minimal amounts
of fluid. No pathological findings could be demonstrated in these patients at contrast
meal studies or gastroscopy. The condition improved spontaneously in six patients who
were discharged after 36-83 postoperative days, respectively. The seventh patient (No
3 in Table 1) was reoperated on at the 36th postoperative day. The gastro-jejunal
anastomosis was found to be intact but a hard inflammatory mass around the remnant
pancreas was found to involve a few centimeters of the posterior side of the jejunum
close to the gastro-entero anastomosis. Following resection ofthe short segment ofthe
affected jejunum, the patient had an uneventful course.
Only one patient developed diabetes (No 2 in Table 1); it.occurred 8 months after
the operation and required regular insulin injections. Four patients had been on
antidiabetic treatment before the operation, one with insulin, the other three with oral
hypoglycaemic agents. The diabetes has postoperatively been stable in these four
patients.
Seven patients are alive (Table 1). Median follow-up period for these patients is 18
months (range 15-29 months). Eighteen patients have died at 4-30 months after the
operation due ’to generalized disease.
DISCUSSION
Arguments for total pancreatectomy in the treatment of pancreatic cancer include the
fact that the disease is potentially multifocal, that a more radical resection of the
regional lymph nodes may be done, and that the degree ofcomplications might be lower
than after p,artial pancreatectomy, mainly because a pancreato-digestive anastomosis
58 16is avoided Proponents of total pancreatectomy also argue that the resulting
diabetes is no longer a great problem. Besides, many patients have diabetes already at
the time ofdiagnosis and will not live long enough to develop secondary complications
to the diabetes.
Others authors, however, consider partial pancreatectomy to be the treatment of
choice5’13-15. This attitude is corroborated by recent reports indicating that partial and
total pancreatectomy are similar with respect to operative mortality and morbidity as
well as long-term survival6’13’15’16. Partial pancreatectomy with a pancreato- digestive
anastomosis also preserves the spleen and the external pancreatic secretion and does
not usually produce diabetes.
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In recent reports, pancreato-duodenectomy for pancreatic cancer has had4a_72i57.lT0/lohospital mortality rate and an overall postoperative morbidity of 20-30%
Most complications have been related to the pancreato-digestive anastomosis6’7’17-2i
The technique used by us is not encumbered with the complications of a pancreato-
digestive anastomosis. Instead, we would expect an increased frequency of pancreatic
fistulas6’17-2, likely, though, to be relatively non-aggressive since most pancreatic
enzymes are not activated. However, ofour 26 patients operated during a 2 year period,
only three patients developed pancreatic fistula (12%), and these fistulas did not cause
significant morbidity. This frequency of pancreatic fistulation is lower than in earlier
reports of subtotal pancreatectomy with closure of the pancreatic remnant 17,32. One
possible explanation for this difference is that closure of the pancreatic remnant has
previously been performed only when it was considered too hazardous to perform a
pancreato-jejunostomy. Another explanation for the comparatively low frequency of
fistulas in our series might be the small pancreatic remnant. However, besides the three
patients developing pancreatic fistula, another 4 developed peripancreatic abscesses,
giving a total complication rate of 27% in the immediate postoperative period.
One can speculate that it might be possible to further reduce the frequency of
pancreatic fistulas by the use of somatostatin or somatostatin analogues in the imme-
diate postoperative period 33,34, or by the use of more suitable stapling devices.
Seven of our patients developed a transient period of delayed gastric emptying and
a delayed recovery of gastrointestinal function. This finding confr,r,s earlier reports
on subtotal pancreatectomy with pancreatodigestive anastomosis J,v. The postoper-
ative gastric stasis might be explained by the slower mobility ofjejunum as compared
to duodenum, to operative damage of the blood or nerve supply to the gastric remnant
or to the jejunum, to peripancreatic inflammatory changes, or to hormonal changes
after the operation 35. This issue is unsettled and it would therefore be of interest to
study the physiological consequences of this type of operation.
In the present series, staplers originally designed for stapling the gastrointestinal
tract, like TA55, were used. These staple the important ducts but usually crush the
pancreatic capsule. In our last eleven operations, a stapler instrument with a larger
distance within the staples, RL60, have been used. Hereby the pancreas may be safely
stapled with an intact pancreatic capsule. However, it is obvious that different stapler-
devices are needed due to the differences in size and degree of fibrosis of the pancreatic
tail. In the future, staplers especially designed for solid organ stapling may be available.
One patient developed overt diabetes 8 months after the operation. This compares
well with the reported 12.5 Vo incidence of diabetes after partial pancreato-duodenec-
11tomy with pancreato-digestive anastomosis Whether other patients developed
impaired glucose tolerance can not be established since glucose tolerance test was not
performed routinely after the operation. The reason why dabetes does not usually
evolve after partial pancreatectomy is probably explained by studies indicating that
more than 70% of the pancreas can be removed from an otherwise healthy gland
without the development of diabetes 37,38. All patients operated on by this technique
develop pancreatic insufficiency and are given pancreatic enzymes. After the postoper-
ative phase, bowel function has been normal. In addition, the weight of the patients
has been stable, and some but not all patients have regained their pre-illness weight.
In summary, subtotal pancreatectomy with closure of the pancreatic remnant has
the advantage ofleaving healthy endocrine pancreatic tissue and the spleen and avoids
a potentially hazardous pancreato-digestive anastomosis. The low operative mortality
and the good quality of life after the operation encourage us to continue the use of this
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technique. It is too early for an accurate evaluation of the long-term results, but the
long- term survival does not seem to be prolonged, at least not when compared to
historical series 12.
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INVITED COMMENTARY
Attempting to prevent the troublesome complication of leakage of the pancreatico-
jejunostomy, the authors have sacrificed exocrine pancreatic function by stapling
closed the ductal system of the pancreatic remnant. In this they have not been entirely
successful as the resulting incidence of temporary pancreatic fistula has been 12%.
Using the expression of Dr. Kenneth Warren, the commentators prefer a "precise
anastomosis" of the pancreatic duct, per se, to a tiny opening in the side of the jejunal
Roux Y. Utilizing 5.0 prolene sutures for the anastomosis and utilizing, tem-
porarily, a small percutaneous catheter through the anastomosis, external
pancreatic fistulae have essentially disappeared.
The authors have not recommended pancreatic stapling in patients undergoing
resection for benign pancreatic disease in whom the life expectancy would be longer.
In such patients, the metabolic deficits, including the possible delayed loss of islet cell
function, might prove too high a price.
In eight patients (31%), gastric stasis after operation proved to be a significant
complication. The commentators have had a similar experience. Doberneck de-
scribed gastric stasis as a major complication in 15 of 57 patients (26%) undergoing
palliative gastrojejunostomy and cholecystojejunostomy for unresectable pancreatic
cancer. They reviewed the relatively limited, earlier literature on the subject and
attributed the problem to technical factors.
The commentators have also found gastric stasis a greater problem in the
patients with bypass gastrojejunostomies (unresected pancreatic cancer) than with
gastrojejunostomy after the Whipple resection, although the latter group is not free
of the problem.
If the biliary jejunal-anastomosis is made upstream from the gastrojejunal anas-
tomosis, it is difficult to position the efferent limb ofthe gastrojejunonostomy along
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the lessor curvature ofthe stomach its "magenstrasse". Positioning the efferent limb
on the greater curvature of the stomach may provide a transient impediment to
gastric emptying. (We do not utilize vagotomy after pancreatic resection or by-
pass.) Repeatedly, endoscopy or reoperation has shown no anastomatic obstruction.
The passage of time has inevitably permitted resumption of adequate anastomotic
function. Meanwhile, the commentators often place a feeding jejunostomy and
sometimes a decompressive gastrostomy tube as an adjunct to palliative bypasses.
Ranitidine (Zantac), widely used postoperatively as a hydrogen ion blocker, has
been observed experimentally to retard gastric emptying in man. Reglan, utilized to
promote gastric motility, has not solved the problem.
Meanwhile, all of our related patients have baseline radionuclear scans of
gastric emptying preoperatively and serially postoperatively, utilizing scrambled
eggs orally into which is mixed a technicum 99 sulphur colloid. Transient, but
troublesome postoperative gastric stasis is frequent. Although gastric atony is
obviously a factor, no study has yet proved whether the fundamental problem has a
technical or physiological basis.
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INVITED COMMENTARY
The paper by Ahren and others shows once again that pancreatoduodenectomy
for cancer can be performed with low mortality. In the last decade hospital mortality
after this procedure has decreased below 5%2, and mortality of more than 10% is
regarded as unacceptable. One should be aware that most reports, such as the one by
Ahren et al come from well-known centres, with special interest and experience
in pancreatic surgery, and although excellent results can be achieved by the occa-
sional ’laancreatectomist’’3, it is fair to say that the results ofmost unpublished series
are not as good.
Hospital mortality is generally considered to bethe yardstick of surgical quality,
but morbidity and long-term sequellae may be just as important since they affect to
a large extent the quality of life after pancreatoduodenectomy. Serious pos-
toperative complications are frequent and occur in about 30%, leading to reoper-
ations, long hospitalisation and high costs4. Breakdown of the pancreato-enteric
anastomosis is the most feared complication that occurs in about 12%J. The mortality
of this complication can be as high as 40%5 but adequate conservatiye treatment2
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or aggressive surgery, completion performing a so-called completion pancrea-
tectomy4, dramatically decreased mortality. Various surgical techniques have been
used to connect the pancreatic remnant to the gastrointestinal tract. The pancreato-
jejunostomy is probably the most physiological and the most frequently used tech-
nique. Either a mucosa to mucosa anastomosis or an invaginating or "dunking"
anastomosis is preferred. Long internal- external splints or short splints are used
or splints are abandoned altogether since they are thought to lead to obstruction
and to have an adverse effect. Duration ofsplinting has also been discussed. Separating
the bile duct and the pancreatic duct by separate jejununal loops as advocated by
Macado et al.7 does not lower the chance of leakage but less serious complications
result since the pancreatic juice is not activated. Pancreatogastrostomy seems an
interesting alternative, having very high success rate. In one collective series where
pancreatogastrotomy was performed only one anastomotic breakdown in 134 pa-
tients was seen. In fact excellent results have been reported of practically all
techniques. And although much emphasis should be given to the technique itself other
factors related to the surgeon or to the patient and his pancreas may play an even
greater role in the outcome after pancreatoduodenectomy. Patient-related factors as
high age, and preoperativejaundice have shown a deleterious effect on anastomosic
healing. Since morbidity and mortality in elderly patients because of anastomotic
breakdown is very highJand the prognosis of pancreatic cancer is poor, a palliative
(non-operative) procedure should be considered instead of pancreatoduodenec-
tomy, for this groupl. It has been suggested that the high incidence of anastomotic
breakdown in jaundiced patients can be lowered by preoperative internal biliary
drainage. And whereas percutaneous transhepatic external, biliary drainage did not
beneficially influence the outcome after surgery, partly because of the complications
of the technique itself11, endoscopic internal drainage has definitely earned its place
in the preoperative treatment ofjaundiced patients.
This procedure has also been advocated by Trede, who changed his opinion about
performing a pancreatoduodenectomy in severely jaundiced patients4. The
condition ofthe pancreas itself influences the success ofpancreato-jejunostomy. The
rate of leakage was 22% in patients with a soft, friable, normal pancreatic remnant
and 6% in patients with a firm fibrotic pancreas5. A large diameter pancreatic duct
has also a beneficial effect on the outcome of a pancreatic anastomosis12. It is
obvious that patients undergoing a pancreatoduodenectomy for chronic pancre-
atitis do much better than patients with pancreatic cancer, since the former patients
are younger, usually non-jaundiced, and have a firm pancreas with a dilated duct.
Reports of the success of pancreato-enterostomies, considering both patients with
malignant and benign disease should be read with the above mentioned in mind.
To circumvent the problems ofthe pancreatic-enteric anastomic, excision, ligation,
staplinl, duct occlusion or open drainage of the pancreatic remnant can be con-3,14,15sidered’1 Total pancreatectomy has been advocated for the same reason and
also because multicentricity of pancreatic cancer has been reported in up to 36% 16.
The hospital mortality of total pancreatectomy was rather high at first, although a
decrease has been reported by Brooks14. This reported decrease together with the
long-term survival of some patients with unsuspected foci ofpancreatic cancer in the
resected pancreatic tail make total pancreatectomy or, even more, the subtotal modi-
fication as described by Ahren et al. worthwhile considering. Most authors,
however, do not report an increased survival after total pancreatectomy17 and the real
drawback of this operation is the surgical diabetes mellitus, that leads to serious
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complications and even death by uncontrollable hypoglycemia7’18’19. Ligation,
stapling, duct occlusion and open drainage are attractive, simple possibilities with
aeptable mortality but a high morbidity according to the literature8’1:’13.
In the present publication under discussion subtotal pancreatectomy and stapling
of the pancreatic remnant leads to a low complication rate. However, it can be argued
that the delayed gastric emptying leading to prolonged hospitalisation in this series
was a result of pancreatitis with infiltration as was actually demonstrated
during relaparotomy in one patient. Non-drainage in the gastrointestinal tract will
definitely result in exocrine pancreatic insufficiently, that is not always easy t treat
and leads to malnutrition, especially in combination with gastric resection’. Fur-
thermore, fibrosis as a result of some form of obstruction of the pancrea,c duct will
lead to endocrine pancreatic function as shown in experimental animals". In 4 out
of 7 long-term survivors this complication was seem after duct occlusion in one study
whereas only. 3 out of 39 patients had diabetes mellitus after pancreato-
jejunostomy5.
The use of stapling devices in pancreatectomy is a very attractive method since it
is easy and gives a bloodless field. By removing a few staples the pancreatic duct can
be opened and a pancreato-jejunostomy can be performed by the invaginating tech-
nique9-. Two pancreatic fistulae were seen in 50 consecutive patients with a friable
pancreas (Obertop, unpublished). As shown in the paper of Ahren et al. mortality of
pancreatoduodenectomy has decreased over the last couple ofyears to a very acceptable
level. Still the short-term and long-term morbidity is considered. Various modifica-
tions of the original procedure as reported by Whipple in 1985:z have been proposed
in order to improve the quality of life. The use of the pylorus preserving type of
pancreatoduodenectomy seems one improvement:. Prevention of pancreatic insuffi-
ciency by use of pancreatoenteric anastomosis may well be another important feature
in that respect, as long as this can be achieved with low risk by an experienced
pancreatectomist.
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